Clinical Research Institute of Ohio
Westlake, Ohio 44145
0 studies enrolling now · 4 studies all time
What they study most
Cirrhosis, Liver, NASH, NASH With Fibrosis, Nonalcoholic Steatohepatitis (NASH), Steatohepatitis, Nonalcoholic, Type 2 Diabetes
Studies at this site
- A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
- HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes — Completed
- A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 — Completed
- A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3 — Completed